Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors

BACKGROUND: Breast cancer is the most prevalent cancer among women. Doxorubicin (DOX) is a common chemotherapeutic drug used to treat many different cancers. However, multidrug resistance limits the treatment of breast cancer. MDR1 siRNA (siMDR1) combinatorial therapy has attracted significant atten...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xin, Wang, Yifan, Chen, Si, Zhang, Shuang, Cui, Chunying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528549/
https://www.ncbi.nlm.nih.gov/pubmed/34703227
http://dx.doi.org/10.2147/IJN.S332830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528549/
https://www.ncbi.nlm.nih.gov/pubmed/34703227
http://dx.doi.org/10.2147/IJN.S332830

Ejemplares similares